Stock Roland

ABSTRACT

Kidney transplantation remains the preferred treatment for individuals with end-stage kidney disease, yet organ shortages continue to limit timely access to transplantation worldwide. For people living with HIV, advances in combination antiretroviral therapy have transformed HIV infection into a manageable chronic condition, allowing transplantation to become a safe and effective therapeutic option. The use of kidneys from HIV-positive donors for HIV-positive recipients has emerged as a promising strategy to expand the donor pool while maintaining favorable clinical outcomes. Early clinical studies and national transplant programs have demonstrated encouraging results, including acceptable graft survival